Skip to main content

Say Hello to ACUVUE® Abiliti™

A powerful approach to managing myopia.

Myopia is a silent epidemic affecting millions of children around the world1—and it is growing fast2. It is the greatest eye health threat of the 21st century3. Research shows that myopia is more than just nearsightedness. It is a chronic, progressive disease associated with a risk of significant complications later in life that threaten to take away our most treasured sense: Sight3-5.

Our Commitment

Our commitment to fighting this global public health crisisWe marvel at the magic of our eyes, yet we are acutely aware there are many who do not fully experience the wonder of this gift.1As one of the world’s most trusted healthcare brands, Johnson & Johnson Vision believes that changing the trajectory of this epidemic is our responsibility. We’re determined to find ways to manage myopia, potentially reducing the risk of sight-threatening complications in later life.We are doing it through our Abiliti™ portfolio.
Our commitment to fighting this global public health crisisWe marvel at the magic of our eyes, yet we are acutely aware there are many who do not fully experience the wonder of this gift.1As one of the world’s most trusted healthcare brands, Johnson & Johnson Vision believes that changing the trajectory of this epidemic is our responsibility. We’re determined to find ways to manage myopia, potentially reducing the risk of sight-threatening complications in later life.We are doing it through our Abiliti™ portfolio.
Our Commitment

Our Commitment

Our commitment to fighting this global public health crisisWe marvel at the magic of our eyes, yet we are acutely aware there are many who do not fully experience the wonder of this gift.1As one of the world’s most trusted healthcare brands, Johnson & Johnson Vision believes that changing the trajectory of this epidemic is our responsibility. We’re determined to find ways to manage myopia, potentially reducing the risk of sight-threatening complications in later life.We are doing it through our Abiliti™ portfolio.

Our Commitment

Our commitment to fighting this global public health crisisWe marvel at the magic of our eyes, yet we are acutely aware there are many who do not fully experience the wonder of this gift.1As one of the world’s most trusted healthcare brands, Johnson & Johnson Vision believes that changing the trajectory of this epidemic is our responsibility. We’re determined to find ways to manage myopia, potentially reducing the risk of sight-threatening complications in later life.We are doing it through our Abiliti™ portfolio.

The Abiliti™ portfolio is a holistic solution built on three main pillars.

See Your Abiliti

The Abiliti™ portfolio is a growing suite of solutions designed to manage myopia. Our goal is to develop solutions that give clearer vision today and better eye health in the future.In combination with our myopia management products, we offer a digital companion called SeeAbiliti™, a personalized mobile app that provides myopia related lifestyle guidance such as increasing time spent outdoors.Download the SeeAbiliti™ App now!Available on:Googleapp storeExplore our Abiliti™ portfolio

Master Your Abiliti

Your eye care professional will receive unparalleled and personalized support, training, and continuing education on myopia through Master Your Abiliti™, administered through our clinical centers of excellence.You can feel confident in knowing that you are receiving state of the art treatment from highly trained clinicians following the latest practices in myopia management. Additionally,
research and evidence on myopia is available to you as well, through the SeeAbiliti™ app.

Share Your Abiliti

Johnson & Johnson Vision believes that every child deserves the gift of clear sight. That’s why we’re committed to the ongoing Sight For Kids® program with our non-profit partner Lions Club International Foundation. And you can be part of this global effort.A 1-for-1 approach: Each annual purchase of an Abiliti™ product will provide a free comprehensive eye exam to a child in need through Sight For Kids®. An eye exam can detect over 270 different medical conditions7, including myopia, and is important in maintaining overall eye health.
Young Asian mother and daughter enjoying the outdoors, glasses-free, which is the goal of Abiliti™ myopia treatments.

With the Abiliti™ portfolio, the power is in your hands.

Together, we can take charge of myopia around the world. Find an Abiliti™ prescriber near you.

Find a Professional
Eye doctor examining girl with opthalmoscope. Monitoring myopia is an important part of myopia treatment.

REFERENCES

1. Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo K, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 to 2050. Ophthalmol. 2016,123(5):1036-1042.
2. Morgan, IG, French, AN, Ashby, RS, Guo, X., Ding, X., He, M. and Rose, KA, 2018. The epidemics of myopia: aetiology and prevention. Progress in retinal and eye research, 62, pp.134-149.
3. Holy C, Kulkarni K, Brennan NA. Predicting Costs and Disability from the Myopia Epidemic – A Worldwide Economic and Social Model. Investigative ophthalmology & visual science. 2019;60(9):5466-5466.
4. Flitcroft DI The complex interactions of retinal, optical and environmental factors in myopia aetiology. Progress in Retinal and Eye Research. 2012 31(6):622-660.
5. Donovan L, Sankaridurg P, Ho A et al Myopia progression rates in urban children wearing single-vision spectacles. OVS 2012;89(1):27-32.
6. Pärssinen O, Kauppinen M. Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood. Acta Ophthalmologica. 2019;97(5):510-518.
7. Systemic Conditions with Ocular and Visual Manifestations. American Optometric Association. December 2019.

PP2022ABLM4273
REFERENCES

REFERENCES

1. Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo K, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 to 2050. Ophthalmol. 2016,123(5):1036-1042.
2. Morgan, IG, French, AN, Ashby, RS, Guo, X., Ding, X., He, M. and Rose, KA, 2018. The epidemics of myopia: aetiology and prevention. Progress in retinal and eye research, 62, pp.134-149.
3. Holy C, Kulkarni K, Brennan NA. Predicting Costs and Disability from the Myopia Epidemic – A Worldwide Economic and Social Model. Investigative ophthalmology & visual science. 2019;60(9):5466-5466.
4. Flitcroft DI The complex interactions of retinal, optical and environmental factors in myopia aetiology. Progress in Retinal and Eye Research. 2012 31(6):622-660.
5. Donovan L, Sankaridurg P, Ho A et al Myopia progression rates in urban children wearing single-vision spectacles. OVS 2012;89(1):27-32.
6. Pärssinen O, Kauppinen M. Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood. Acta Ophthalmologica. 2019;97(5):510-518.
7. Systemic Conditions with Ocular and Visual Manifestations. American Optometric Association. December 2019.

PP2022ABLM4273